Table 1 Characteristics of included studies
From: Similarities and differences between MIS-C and KD: a systematic review and meta-analysis
First author | year | country | Study period | Intervention group | inclusion standards | number | Control group | number | NOS score |
|---|---|---|---|---|---|---|---|---|---|
Carbajal, R [10]. | 2020 | France | MIS-C: Apr.1-Jul. 15,2020; KD: jan.1,2018-Jul.15 2020. | MIS-C | WHO CDC RCOPC | 7 | KD | 40 | 7 |
Cattalini, M [21]. | 2021 | Italy | MIS-C: Feb.1-May31, 2020; KD:2000-2019 | PIMS-TS | RCOPC | 53 | KD | 96 | 7 |
Cherqaoui, B [22]. | 2021 | France | MIS-C: 2020; KD:2011-2014 | PIMS | NA | 404 | KD | 425 | 6 |
Consiglio, C. R [20]. | 2020 | Italy and Sweden | MIS-C:Mar.17-May15 2020; KD: Mar. 2017-May 2019 | MIS-C | WHO | 13 | KD | 28 | 6 |
Corwin, D. J [23]. | 2020 | US | MIS-C: Mar.1-May 15 2020; KD: 2019 | MIS-C-KD | CDC | 8 | KD | 15 | 8 |
Esteve-Sole, A [19]. | 2021 | Spain | MIS-C: Apr. 23–Jun. 5, 2020; KD: 2016–2019 | MIS-C | WHO RCOPC | 14 | KD | 14 | 8 |
Felsenstein, S [18]. | 2021 | UK | MIS-C:Mar.2020-Mar.2021; KD: Feb. 2005-Feb. 2020 | PIMS-TS | CDC RCOPC | 34 | KD | 27 | 8 |
Gaitonde, M [17]. | 2020 | US | MIS-C: Mar.-Jun.2020; KD : Jan. - Jun. 2019 | MIS-C | CDC | 12 | KD | 12 | 7 |
Godfred, S [16]. | 2022 | US | MIS-C:Mar.16, 2020- Feb.21, 2021; KD: Jan.2019- Dec. 2019 | MIS-C | CDC | 233 | KD | 101 | 7 |
Kostik, M. M [15]. | 2021 | Russia | MIS-C: May 2020-Apr.2021; KD:Sep. 2010-Feb. 2021 | MIS-C | WHO | 72 | KD | 147 | 7 |
Lee, P. Y [14]. | 2020 | US | MIS-C:March to June 2020; KD: May 2019- Feb. 2020 | MIS-C | WHO CDC RCOPC | 28 | KD | 40 | 7 |
Matsubara, D [13]. | 2020 | US | MIS-C: Apr. 10-Jun. 7, 2020; KD:Jan.2019 - Dec.2019 | MIS-C | WHO CDC | 28 | KD | 20 | 8 |
Mohsin, S. S [12]. | 2021 | Pakistan | MIS-C: May-Aug. 31,2020; KD: in the last five years prior to this pandemic | MIS-C-KD | WHO* | 12 | KD | 30 | 7 |
Whittaker, E [11]. | 2020 | UK | MIS-C: Mar. 23-May 16, 2020; KD:2002–2019 | PIMS-TS | WHO CDC RCOPC | 58 | KD | 1132 | 7 |